A business in context

YARW research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-11-17 · 7996 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 10-Q · Quarterly report

    Report date 2026-09-30 · 0001566044-26-000019

  2. 8-K · Current report

    Report date 2026-11-12 · 0001566044-26-000017 · Items 2.02,9.01

  3. 4 · Ownership change

    Report date 2026-10-29 · 0001104659-26-120657

  4. 4 · Ownership change

    Report date 2026-10-29 · 0001104659-26-120656

  5. 4 · Ownership change

    Report date 2026-10-29 · 0001104659-26-120654

  6. 4 · Ownership change

    Report date 2026-10-29 · 0001104659-26-120652

  7. 4 · Ownership change

    Report date 2026-10-29 · 0001104659-26-120647

  8. 8-K · Current report

    Report date 2026-09-10 · 0001104659-26-107485 · Items 1.01,9.01

  9. 8-K · Current report

    Report date 2026-09-10 · 0001104659-26-106699 · Items 8.01,9.01

  10. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001566044-26-000010

  11. 8-K/A · Current report

    Report date 2026-07-24 · 0001104659-26-095925 · Items 2.02,7.01,9.01

  12. 4 · Ownership change

    Report date 2026-07-29 · 0001104659-26-088665

  13. 8-K · Current report

    Report date 2026-07-29 · 0001104659-26-088662 · Items 8.01

  14. 4 · Ownership change

    Report date 2026-07-27 · 0001104659-26-088371

  15. 4 · Ownership change

    Report date 2026-07-27 · 0001104659-26-088370

  16. 8-K · Current report

    Report date 2026-07-24 · 0001104659-26-087601 · Items 1.01,2.01,2.02,3.02,3.03,5.01,5.02,5.03,5.05,7.01,9.01

  17. 8-K · Current report

    Report date 2026-07-21 · 0001104659-26-085235 · Items 7.01,8.01,9.01

  18. 8-K · Current report

    Report date 2026-07-16 · 0001104659-26-084760 · Items 5.07

  19. 8-K · Current report

    Report date 2026-07-14 · 0001104659-26-083356 · Items 7.01,9.01

  20. 8-K · Current report

    Report date 2026-07-10 · 0001104659-26-082433 · Items 7.01,8.01,9.01

  21. 8-K · Current report

    Report date 2026-05-21 · 0001104659-26-065214 · Items 7.01,9.01

  22. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001566044-26-000005

  23. 8-K · Current report

    Report date 2026-03-11 · 0001104659-26-026439 · Items 3.01

  24. 10-K · Annual report

    Report date 2025-12-31 · 0001566044-26-000002

  25. 8-K · Current report

    Report date 2026-01-30 · 0001104659-26-008642 · Items 1.01,9.01

  26. 8-K · Current report

    Report date 2025-12-17 · 0001104659-25-121828 · Items 1.01,3.02,5.01,5.02,7.01,9.01

  27. 8-K · Current report

    Report date 2025-12-12 · 0001104659-25-120637 · Items 5.07

  28. DEF 14A · Proxy statement

    Report date 2025-12-12 · 0001104659-25-110346

  29. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001566044-25-000010

  30. 8-K · Current report

    Report date 2025-11-06 · 0001566044-25-000007 · Items 2.02,9.01

  31. 8-K · Current report

    Report date 2025-09-11 · 0001104659-25-089531 · Items 3.01

  32. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001628280-25-040366

  33. 8-K · Current report

    Report date 2025-08-11 · 0001104659-25-078135 · Items 2.02,5.02,9.01

  34. 8-K · Current report

    Report date 2025-07-30 · 0001104659-25-071953 · Items 2.02,8.01,9.01

  35. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001628280-25-023740

  36. 8-K · Current report

    Report date 2025-05-08 · 0001628280-25-023478 · Items 2.02,9.01

  37. 10-K · Annual report

    Report date 2024-12-31 · 0001628280-25-010908

  38. 8-K · Current report

    Report date 2025-03-06 · 0001628280-25-010777 · Items 2.02,9.01

  39. 8-K · Current report

    Report date 2025-01-13 · 0001104659-25-002862 · Items 8.01,9.01

  40. 8-K · Current report

    Report date 2024-12-23 · 0001104659-24-131064 · Items 8.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-11-14 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 2 transaction rows2AExercise / conversion: 0 transaction rows0MTax / exercise payment: 8 transaction rows8FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

12 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-07-29
2026-07-30
RTW Fund Group GP, LLC; WONG RODERICKJ · Other (see filing)
Disposed
Common Stock133290.00.0
2026-07-29
2026-07-30
RTW Fund Group GP, LLC; WONG RODERICKJ · Other (see filing)
Acquired
Pre-Funded Warrants (Right to Buy)
Derivative security
133290.00.0
2026-07-27
2026-07-29
Ashiya MonaA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
15435.00.0
2026-07-27
2026-07-29
Zeronda TylerA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
185798.00.0
2026-07-23
2026-07-24
Zeronda TylerF · Tax / exercise payment
Disposed
Common Stock22516.00.9
2026-07-23
2026-07-24
Harsch MutyaF · Tax / exercise payment
Disposed
Common Stock22516.00.9
2026-07-23
2026-07-24
Domzalski DavidF · Tax / exercise payment
Disposed
Common Stock79391.00.9
2026-07-23
2026-07-24
Stuart IainF · Tax / exercise payment
Disposed
Common Stock15405.00.9
2026-06-30
2026-07-02
Zeronda TylerF · Tax / exercise payment
Disposed
Common Stock3464.00.65
2026-06-30
2026-07-02
Harsch MutyaF · Tax / exercise payment
Disposed
Common Stock3464.00.65
2026-06-30
2026-07-02
Domzalski DavidF · Tax / exercise payment
Disposed
Common Stock12214.00.65
2026-06-30
2026-07-02
Stuart IainF · Tax / exercise payment
Disposed
Common Stock2370.00.65

Identity & relationships

Wikidata structured data · retrieved 2026-11-14 · 1656 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001566044Yarrow Bioscience, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-11-14 · 1196 checked identities; 0 unavailable records

Search names and former names
  • VYNE Therapeutics Inc. · former SEC name · 2020-09-08 to 2026-07-24
  • Menlo Therapeutics Inc. · former SEC name · 2017-11-28 to 2020-09-02
  • Menlo Therapeutics, Inc. · former SEC name · 2017-07-28 to 2018-01-31
  • Tigercat Pharma, Inc. · former SEC name · 2013-01-07 to 2013-01-07

Revenue in constant purchasing power

USD revenue expressed in 2026-10 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$501.0K$539.0K
2023-12-31$424.0K$469.6K
2022-12-31$477.0K$550.0K
2021-12-31$931.0K$1.16M
2020-12-31$20.99M$27.38M
2019-12-31$443.0K$584.8K
2018-12-31$3.60M$4.83M

Bureau of Labor Statistics · retrieved 2026-11-17 · 9 selected series; gaps remain missing

Explore the CPI history ↗